MedPath

TAXELDO (Docetaxel Concentrate for Solution for Infusion 20mg/ml)

Registration Number: MAL25036150AZ

Approved
Approval ID

f0f9ae94d8a0e4aa

Registration Number

MAL25036150AZ

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types3 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (3)

160mg / 8 mlAvailable
Package Size: 160mg / 8 ml
Status: NPRA Approved
20mg / 1 mlAvailable
Package Size: 20mg / 1 ml
Status: NPRA Approved
80mg / 4 mlAvailable
Package Size: 80mg / 4 ml
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

DOCETAXEL TRIHYDRATEActive
Monograph: docetaxel trihydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TAXELDO (Docetaxel Concentrate for Solution for Infusion 20mg/ml) - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform